ArticleJAAD case reports2026

SJS/TEN following therapy with pembrolizumab and enfortumab vedotin in a patient with urothelial carcinoma.

Natalie Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.